Organogenesis: Q3 Earnings Snapshot
In this article:
CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Thursday reported profit of $3.2 million in its third quarter.
On a per-share basis, the Canton, Massachusetts-based company said it had net income of 2 cents.
The regenerative medicine company posted revenue of $108.5 million in the period.
Organogenesis expects full-year revenue in the range of $433 million to $446 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORGO at https://www.zacks.com/ap/ORGO
